Palomar Stock Forecast, Price & News

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Palomar in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Palomar stock.
View analyst ratings for Palomar or view top-rated stocks.

Wall Street analysts have given Palomar a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Palomar wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Palomar is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Palomar.

Palomar will be holding an earnings conference call on Thursday, August 5th at 12:00 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13721260".

Palomar Holdings, Inc. (NASDAQ:PLMR) issued its quarterly earnings data on Wednesday, May, 5th. The company reported $0.73 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.51 by $0.22. The business earned $49.98 million during the quarter, compared to the consensus estimate of $51.11 million. Palomar had a trailing twelve-month return on equity of 4.16% and a net margin of 6.26%.
View Palomar's earnings history.

Palomar's stock was trading at $47.51 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PLMR stock has increased by 71.4% and is now trading at $81.43.
View which stocks have been most impacted by COVID-19.

4 brokerages have issued twelve-month target prices for Palomar's shares. Their forecasts range from $78.00 to $125.00. On average, they expect Palomar's share price to reach $100.80 in the next year. This suggests a possible upside of 23.8% from the stock's current price.
View analysts' price targets for Palomar or view top-rated stocks among Wall Street analysts.

Some companies that are related to Palomar include RenaissanceRe (RNR), Enstar Group (ESGR), Lemonade (LMND), RLI (RLI), Selective Insurance Group (SIGI), The Hanover Insurance Group (THG), AXIS Capital (AXS), Kemper (KMPR), Kinsale Capital Group (KNSL), White Mountains Insurance Group (WTM), Mercury General (MCY), State Auto Financial (STFC), Horace Mann Educators (HMN), SiriusPoint (SPNT) and Employers (EIG).
View all of PLMR's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Palomar investors own include Advanced Micro Devices (AMD), NVIDIA (NVDA), DocuSign (DOCU), CrowdStrike (CRWD), Taiwan Semiconductor Manufacturing (TSM), Teladoc Health (TDOC), The Trade Desk (TTD), Beyond Meat (BYND), Dynatrace (DT) and Roku (ROKU).

(PLMR) raised $63 million in an initial public offering (IPO) on Wednesday, April 17th 2019. The company issued 5,600,000 shares at a price of $5.00-$17.62 per share. Barclays, J.P. Morgan and Keefe, Woods & Bruyette (A Stifel Company) served as the underwriters for the IPO and Evercore ISI, William Blair, Sandler O'Neill + Partners and SunTrust Robinson Humphrey were co-managers.

Palomar trades on the NASDAQ under the ticker symbol "PLMR."

Palomar's stock is owned by many different institutional and retail investors. Top institutional shareholders include Villere ST Denis J & Co. LLC (3.88%), Emerald Mutual Fund Advisers Trust (1.64%), Emerald Advisers LLC (1.45%), Kornitzer Capital Management Inc. KS (0.97%), Aegon Asset Management UK PLC (0.40%) and Oak Ridge Investments LLC (0.22%). Company insiders that own Palomar stock include Andrew T Robinson, Britt Morries, George L Estes III, Heath A Fisher, Jon Christianson, Mac Armstrong, Martha Notaras, Michelle Antoinette Johnson, Richard H Taketa, Richard Rosso, Robert E Dowdell, T Christopher Uchida and Vi Gp Aiv Ltd Genstar.
View institutional ownership trends for Palomar.

PLMR stock was sold by a variety of institutional investors in the last quarter, including Alliancebernstein L.P., Ziegler Capital Management LLC, Oak Ridge Investments LLC, Aegon Asset Management UK PLC, and Bellecapital International Ltd.. Company insiders that have sold Palomar company stock in the last year include Britt Morries, Heath A Fisher, Jon Christianson, Mac Armstrong, Michelle Antoinette Johnson, Richard Rosso, Robert E Dowdell, and T Christopher Uchida.
View insider buying and selling activity for Palomar or view top insider-selling stocks.

PLMR stock was purchased by a variety of institutional investors in the last quarter, including Villere ST Denis J & Co. LLC, Emerald Advisers LLC, Kornitzer Capital Management Inc. KS, Emerald Mutual Fund Advisers Trust, Conestoga Capital Advisors LLC, and State of Alaska Department of Revenue. Company insiders that have bought Palomar stock in the last two years include Martha Notaras, Richard H Taketa, and Robert E Dowdell.
View insider buying and selling activity for Palomar or or view top insider-buying stocks.

Shares of PLMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of PLMR stock can currently be purchased for approximately $81.43.

Palomar has a market capitalization of $2.08 billion and generates $168.46 million in revenue each year. The company earns $6.26 million in net income (profit) each year or $0.35 on an earnings per share basis.

Palomar employs 122 workers across the globe.

The official website for Palomar is www.palomarspecialty.com.

Palomar is headquartered at 7979 IVANHOE AVENUE SUITE 500, LA JOLLA CA, 92037.

Palomar's mailing address is 7979 IVANHOE AVENUE SUITE 500, LA JOLLA CA, 92037. The company can be reached via phone at 619-567-5290 or via email at [email protected]